India Approves Qdenga Dengue Vaccine for 4-60-Year-Olds
India approved its first dengue vaccine, Qdenga, for individuals aged 4–60 after the CDSCO granted marketing authorization following global and local clinical trials. The live-attenuated tetravalent … Read more